Advances of Zinc Signaling Studies in Prostate Cancer

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Jan 23

PMID 31963946

Citations 29

Authors

Dangdang Li

Daniel B Stovall

Wenmeng Wang

Guangchao Sui

Affiliations

Soon will be listed here.

Abstract

Prostate cancer (PCa) is one of the most common cancers and the second leading cause of cancer-related death among men worldwide. Despite progresses in early diagnosis and therapeutic strategies, prognosis for patients with advanced PCa remains poor. Noteworthily, a unique feature of healthy prostate is its highest level of zinc content among all soft tissues in the human body, which dramatically decreases during prostate tumorigenesis. To date, several reviews have suggested antitumor activities of zinc and its potential as a therapeutic strategy of PCa. However, an overview about the role of zinc and its signaling in PCa is needed. Here, we review literature related to the content, biological function, compounds and clinical application of zinc in PCa. We first summarize zinc content in prostate tissue and sera of PCa patients with their clinical relevance. We then elaborate biological functions of zinc signaling in PCa on three main aspects, including cell proliferation, death and tumor metastasis. Finally, we discuss clinical applications of zinc-containing compounds and proteins involved in PCa signaling pathways. Based on currently available studies, we conclude that zinc plays a tumor suppressive role and can serve as a biomarker in PCa diagnosis and therapies.

Citing Articles

Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy.

Bhatnagar K, Jha K, Dalal N, Patki N, Gupta G, Kumar A Front Immunol. 2024; 15:1442788.

PMID: 39676876 PMC: 11638209. DOI: 10.3389/fimmu.2024.1442788.

Dextran-Graft-Polyacrylamide/Zinc Oxide Nanoparticles Inhibit of Cancer Cells in vitro and in vivo.

Virych P, Virych P, Prokopiuk V, Onishchenko A, Ischenko M, Doroschuk V Int J Nanomedicine. 2024; 19:11719-11743.

PMID: 39553459 PMC: 11566607. DOI: 10.2147/IJN.S485106.

Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction.

Wang K, Chen M, Yan S, Han Y, Yuan H, Liu Q Oncogene. 2024; 44(1):8-18.

PMID: 39438763 DOI: 10.1038/s41388-024-03195-x.

Assessment of the Impact of Trace Essential Metals on Cancer Development.

Gorska A, Markiewicz-Gospodarek A, Trubalski M, Zerebiec M, Poleszak J, Markiewicz R Int J Mol Sci. 2024; 25(13).

PMID: 38999951 PMC: 11241304. DOI: 10.3390/ijms25136842.

Emerging Perspectives in Zinc Transporter Research in Prostate Cancer: An Updated Review.

Acevedo S, Segovia M, De la Fuente-Ortega E Nutrients. 2024; 16(13).

PMID: 38999774 PMC: 11243615. DOI: 10.3390/nu16132026.

References

Gudipaty S, Conner C, Rosenblatt J, Montell D . Unconventional Ways to Live and Die: Cell Death and Survival in Development, Homeostasis, and Disease. Annu Rev Cell Dev Biol. 2018; 34:311-332. PMC: 6791364. DOI: 10.1146/annurev-cellbio-100616-060748. View

Costello L, Franklin R . Zinc is decreased in prostate cancer: an established relationship of prostate cancer!. J Biol Inorg Chem. 2010; 16(1):3-8. PMC: 3735606. DOI: 10.1007/s00775-010-0736-9. View

Darago A, Sapota A, Matych J, Nasiadek M, Skrzypinska-Gawrysiak M, Kilanowicz A . The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer. Clin Chem Lab Med. 2011; 49(10):1699-705. DOI: 10.1515/CCLM.2011.651. View

Kolenko V, Teper E, Kutikov A, Uzzo R . Zinc and zinc transporters in prostate carcinogenesis. Nat Rev Urol. 2013; 10(4):219-26. PMC: 3702371. DOI: 10.1038/nrurol.2013.43. View

Kroncke K . Zinc finger proteins as molecular targets for nitric oxide-mediated gene regulation. Antioxid Redox Signal. 2001; 3(4):565-75. DOI: 10.1089/15230860152542934. View

Cortesi M, Chechik R, Breskin A, Vartsky D, Ramon J, Raviv G . Evaluating the cancer detection and grading potential of prostatic-zinc imaging: a simulation study. Phys Med Biol. 2009; 54(3):781-96. DOI: 10.1088/0031-9155/54/3/020. View

Apte R, Chen D, Ferrara N . VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019; 176(6):1248-1264. PMC: 6410740. DOI: 10.1016/j.cell.2019.01.021. View

Franklin R, Feng P, Milon B, Desouki M, Singh K, Kajdacsy-Balla A . hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005; 4:32. PMC: 1243239. DOI: 10.1186/1476-4598-4-32. View

Kambe T, Hashimoto A, Fujimoto S . Current understanding of ZIP and ZnT zinc transporters in human health and diseases. Cell Mol Life Sci. 2014; 71(17):3281-95. PMC: 11113243. DOI: 10.1007/s00018-014-1617-0. View

10.

Lee Y, Lim C . Factors controlling the reactivity of zinc finger cores. J Am Chem Soc. 2011; 133(22):8691-703. DOI: 10.1021/ja202165x. View

11.

Wakwe V, Odum E, Amadi C . The impact of plasma zinc status on the severity of prostate cancer disease. Investig Clin Urol. 2019; 60(3):162-168. PMC: 6495034. DOI: 10.4111/icu.2019.60.3.162. View

12.

Hu Y, Zhang H, Dong L, Xu M, Zhang L, Ding W . Enhancing tumor chemotherapy and overcoming drug resistance through autophagy-mediated intracellular dissolution of zinc oxide nanoparticles. Nanoscale. 2019; 11(24):11789-11807. DOI: 10.1039/c8nr08442d. View

13.

Farashi S, Kryza T, Clements J, Batra J . Post-GWAS in prostate cancer: from genetic association to biological contribution. Nat Rev Cancer. 2018; 19(1):46-59. DOI: 10.1038/s41568-018-0087-3. View

14.

Hojyo S, Miyai T, Fujishiro H, Kawamura M, Yasuda T, Hijikata A . Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength. Proc Natl Acad Sci U S A. 2014; 111(32):11786-91. PMC: 4136588. DOI: 10.1073/pnas.1323557111. View

15.

Hsieh C, Botta G, Gao S, Li T, Van Allen E, Treacy D . PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy. Cancer Res. 2015; 75(10):1944-8. PMC: 4433564. DOI: 10.1158/0008-5472.CAN-14-3602. View

16.

Ishii K, Usui S, Sugimura Y, Yoshida S, Hioki T, Tatematsu M . Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. Int J Cancer. 2001; 92(1):49-54. View

17.

Quigley D, Dang H, Zhao S, Lloyd P, Aggarwal R, Alumkal J . Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 2018; 174(3):758-769.e9. PMC: 6425931. DOI: 10.1016/j.cell.2018.06.039. View

18.

Prasad A, Kucuk O . Zinc in cancer prevention. Cancer Metastasis Rev. 2003; 21(3-4):291-5. DOI: 10.1023/a:1021215111729. View

19.

Fu S, Wan X, Du C, Wang H, Zhou J, Wang Z . A novel fluorescent probe for the early detection of prostate cancer based on endogenous zinc sensing. Prostate. 2019; 79(12):1378-1385. DOI: 10.1002/pros.23844. View

20.

Leitzmann M, Stampfer M, Wu K, Colditz G, Willett W, Giovannucci E . Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst. 2003; 95(13):1004-7. DOI: 10.1093/jnci/95.13.1004. View